Skip to content
10-K

Annual Report

Q BIOMED INC.

0001410578-23-001376

← back to feed
Filed
May 26, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · May 24, 2023 144.09M sh
Shares Diluted FY 2022 · Nov 30, 2022 44.76M sh
Shares Diluted FY 2022 · Nov 30, 2021 26.78M sh
Operating Cash Flow FY 2022 · Nov 30, 2022 $1.94M
Operating Cash Flow FY 2022 · Nov 30, 2021 −$4.3M
Short Term Debt FY 2022 · Nov 30, 2022 $4.11M
Short Term Debt FY 2022 · Nov 30, 2021 $3.05M
Stockholders Equity FY 2022 · Nov 30, 2022 −$4.62M
Stockholders Equity FY 2022 · Nov 30, 2021 −$4.69M
Stockholders Equity FY 2022 · Nov 30, 2020 −$1.08M
Current Liabilities FY 2022 · Nov 30, 2022 $8.13M
Current Liabilities FY 2022 · Nov 30, 2021 $5.49M
Total Liabilities FY 2022 · Nov 30, 2022 $8.13M
Total Liabilities FY 2022 · Nov 30, 2021 $5.49M
Current Assets FY 2022 · Nov 30, 2022 $72.32K
Current Assets FY 2022 · Nov 30, 2021 $459.48K
Total Assets FY 2022 · Nov 30, 2022 $3.52M
Total Assets FY 2022 · Nov 30, 2021 $809.48K
Eps Diluted FY 2022 · Nov 30, 2022 −$0.08
Eps Diluted FY 2022 · Nov 30, 2021 −$0.33
Eps Basic FY 2022 · Nov 30, 2022 −$0.08
Eps Basic FY 2022 · Nov 30, 2021 −$0.33
Rd Expense FY 2022 · Nov 30, 2022 $125.38K
Rd Expense FY 2022 · Nov 30, 2021 $1.07M
Net Income FY 2022 · Nov 30, 2022 −$2.05M
Net Income FY 2022 · Nov 30, 2021 −$8.24M
Operating Income FY 2022 · Nov 30, 2022 −$3.45M
Operating Income FY 2022 · Nov 30, 2021 −$7.39M
Gross Profit FY 2022 · Nov 30, 2022 −$8.99K
Gross Profit FY 2022 · Nov 30, 2021 −$51.25K
Cost Of Revenue FY 2022 · Nov 30, 2022 $293.34K
Cost Of Revenue FY 2022 · Nov 30, 2021 $246.85K
Revenue FY 2022 · Nov 30, 2022 $284.35K
Revenue FY 2022 · Nov 30, 2021 $195.6K
Stock Issued FY 2022 · Feb 26, 2021 100K sh